Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „enzalutamide“
Suchtreffer
Begriffe & Kennungen
Enzalutamide Viatris · 4.5 · MRP2, OAT3 and OCT1 substrates Based on in vitro data, inhibition of MRP2 (in the intestine), as well as organ
Eintrag öffnenEnzalutamide Viatris · 4.5 · Medicinal products which prolong the QT interval Since androgen deprivation treatment may prolong the QT inter
Eintrag öffnenEnzalutamide Viatris · 4.5 · P-gp substrates In vitro data indicate that enzalutamide may be an inhibitor of the efflux transporter P-gp. A
Eintrag öffnenEnzalutamide Viatris · 4.5 · Potential for enzalutamide to affect exposures to other medicinal products
Eintrag öffnenEnzalutamide Viatris · 4.5 · Potential for other medicinal products to affect enzalutamide exposures
Eintrag öffnenEnzalutamide Viatris · 4.5 · The full induction potential of enzalutamide may not occur until approximately 1 month after the start of trea
Eintrag öffnenEnzalutamide Viatris · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenEnzalutamide Viatris · 4.8 Undesirable effects · 1
Eintrag öffnenEnzalutamide Viatris · 4.8 · 10 were treated with enzalutamide plus leuprolide, and was observed in 1 patient (0.3%) treated with placebo p
Eintrag öffnenEnzalutamide Viatris · 4.8 · Adverse reactions observed during clinical studies are listed below by frequency category. Frequency categorie
Eintrag öffnenEnzalutamide Viatris · 4.8 · Breast tenderness In the EMBARK study, breast tenderness (all grades) was observed in 4 of 353 patients (1.1%)
Eintrag öffnenEnzalutamide Viatris · 4.8 · Description of selected adverse reactions
Eintrag öffnenEnzalutamide Viatris · 4.8 · Gynaecomastia In the EMBARK study, gynaecomastia (all grades) was observed in 31 of 353 patients (8.8%) who we
Eintrag öffnenEnzalutamide Viatris · 4.8 · In the 9785-CL-0403 (UPWARD) single-arm trial to assess incidence of seizure in patients with predisposing fac
Eintrag öffnenEnzalutamide Viatris · 4.8 · In the EMBARK study, ischemic heart disease occurred in 6.2% of patients treated with enzalutamide plus leupro
Eintrag öffnenEnzalutamide Viatris · 4.8 · Ischemic Heart Disease In randomised placebo-controlled clinical studies, ischemic heart disease occurred in 3
Eintrag öffnenEnzalutamide Viatris · 4.8 · MedDRA System organ class Adverse reaction and frequency Blood and lymphatic system Uncommon: leucopenia, neut
Eintrag öffnenEnzalutamide Viatris · 4.8 · Nipple pain In the EMBARK study, nipple pain (all grades) was observed in 13 of 353 patients (3.7%) who were t
Eintrag öffnenEnzalutamide Viatris · 4.8 · Rare cases of posterior reversible encephalopathy syndrome have been reported in enzalutamide-treated patients
Eintrag öffnenEnzalutamide Viatris · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnen